Kowa Pharmaceutical Europe Co. Ltd.

Kowa Company, Ltd. Grants Abbott Exclusive Rights to Market Pitavastatin Calcium, a Lipid-lowering Drug, in Australia and New Zealand

WOKINGHAM, England, June 28, 2010 - Following an enthusiastic expansion programme into new markets, Kowa Company, Ltd.